Previous Close | 28.07 |
Open | 28.22 |
Bid | 28.17 x 200 |
Ask | 28.23 x 200 |
Day's Range | 28.11 - 28.37 |
52 Week Range | 25.92 - 34.65 |
Volume | |
Avg. Volume | 2,753,968 |
Market Cap | 16.854B |
Beta (5Y Monthly) | 0.47 |
PE Ratio (TTM) | 15.85 |
EPS (TTM) | 1.78 |
Earnings Date | Aug 06, 2024 - Aug 12, 2024 |
Forward Dividend & Yield | 0.84 (2.98%) |
Ex-Dividend Date | May 16, 2024 |
1y Target Est | 45.33 |
NEW YORK, May 13, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in the following upcoming investor conferences during the month of May: RBC Capital Markets 2024 Global Healthcare Conference on Tuesday, May 14 at 9:00 a.m. ETBofA Securities 2024 Healthcare Conference on Wednesday, May 15 at 6:00 p.m. ET / 3:00 p.m. PT The webcasts will be accessible from Royalty Pharma’s “Events” page at https://www.royaltypharma.com/investors/events/. Webcast
Last week saw the newest quarterly earnings release from Royalty Pharma plc ( NASDAQ:RPRX ), an important milestone in...
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Royalty...